Medtronic’s Continuous Glucose Monitoring System Receives FDA Approval

by Kathy Jones on  November 24, 2011 at 6:35 PM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

Minnesota-based medical technology company Medtronic has revealed that it has received approval from the Food and Drug Administration for its next generation Professional continuous glucose monitoring system, iPro2.
 Medtronic’s Continuous Glucose Monitoring System Receives FDA Approval
Medtronic’s Continuous Glucose Monitoring System Receives FDA Approval

The company said that the Professional CGM can be used by healthcare professionals to get a complete picture of a patient's glucose control and can be used to record low (hypoglycemia) and high (hyperglycemia) glucose excursions which can lead to more serious health complications.

iPro2 will help healthcare professionals to get more information on how diet, medication, and daily activities affect glucose levels in their patients. This information can be used to tailor treatment regimens for optimal control of blood glucose levels.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Diabetes - Foot Care Sugar: Time to Look beyond Its Sweetness Diabetic Ketoacidosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive